首页> 外文期刊>Current pharmaceutical design >Strategies of Overcoming the Physiological Barriers for Tumor-Targeted Nano-Sized Drug Delivery Systems
【24h】

Strategies of Overcoming the Physiological Barriers for Tumor-Targeted Nano-Sized Drug Delivery Systems

机译:克服针对肿瘤的纳米药物递送系统的生理障碍的策略

获取原文
获取原文并翻译 | 示例
           

摘要

Nano drug delivery systems (NDDSs) have been widely used in tumor-targeted therapy since they can effectively reduce the side effects of traditional antitumor drugs and improve the anti-tumor effect. We divided the in vivo process of tumor-targeted NDDSs into seven steps: blood circulation, tumor accumulation, tumor tissue penetration, target cells internalization, lysosome escape, drug release and drug response. In each step, NDDSs will encounter different types of barriers preventing their effective delivery or response. The researchers have been making efforts to find different strategies of overcoming the corresponding barriers for NDDSs. Hence, we here reviewed the recent progress of NDDSs in breaking the physiological barriers for more effective in vivo anti-tumor effect, in order to shed a new perspective on the development of tumor-targeted NDDSs.
机译:纳米药物递送系统(NDDSs)已被广泛用于肿瘤靶向治疗,因为它们可以有效降低传统抗肿瘤药物的副作用并提高抗肿瘤效果。我们将靶向肿瘤的NDDS的体内过程分为七个步骤:血液循环,肿瘤蓄积,肿瘤组织渗透,靶细胞内在化,溶酶体逸出,药物释放和药物反应。在每个步骤中,NDDS都会遇到不同类型的障碍,从而阻碍其有效传递或响应。研究人员一直在努力寻找克服NDDS相应障碍的不同策略。因此,我们在这里综述了NDDSs在打破生理学障碍以更有效地体内抗肿瘤作用方面的最新进展,从而为靶向肿瘤的NDDSs的发展提供了新的视角。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号